BMC infectious diseases · 2026
Utility of recombinant Schistosoma bovis 22.6 kDa antigen for diagnosis of human urogenital schistosomiasis by ELISA: a cross-sectional study in Yewa North LGA, Ogun State, Nigeria.
СтатьяОценочное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Anumudu Chiaka, Ola Abiola, Efenovwe Maureen, Awobode Oluwayemisi, Ebuh Rachael, Akpabio Cephas, Anthony Christopher, Banjo Taiwo, Awobode Henrietta, Trelis Maria, Marcilla Antonio, Oleaga Ana
Аннотация
BACKGROUND: In many endemic regions, accurately diagnosing urogenital schistosomiasis remains challenging, particularly in cases of low-intensity infection and limited laboratory capacity. Exploring antigens that cross-react between related schistosome species provides a promising alternative to conventional diagnostic approaches. Schistosoma bovis-an animal parasite closely related to S. haematobium and sharing the same Bulinus snail hosts in overlapping habitats- is a strong candidate for such studies. This work therefore assessed whether the recombinant S. bovis 22.6 kDa antigen (rSb22.6 kDa) could detect anti-schistosome antibodies in urine samples from individuals living in S. haematobium-endemic communities in Nigeria.
METHODS: Urine samples from 559 individuals (290 adults and 269 children; 235 males and 313 females) from four communities and schools in Yewa North Local Government Area, Ogun State, Nigeria, were collected. Samples were examined for S. haematobium eggs by microscopy, screened for anti-schistosomal antibodies using rSb 22.6 kDa ELISA, and analyzed for haematuria, leukocyturia, and proteinuria using reagent strips.
RESULTS: Prevalence by microscopy was 13.9% (78/558), while 54.1% (299/553) of samples were seropositive by ELISA. Among ELISA-positive individuals, 29.8% had haematuria, 47.9% had leukocyturia, and 37.1% had proteinuria. Of 480 microscopy-negative individuals, 221 (46.0%) were ELISA-positive. When microscopy was used as the reference standard, the rSb 22.6 kDa-ELISA showed 46.2% sensitivity and 45.8% specificity. However, ELISA positivity correlated significantly with clinical markers of urogenital pathology (P < 0.05).
CONCLUSION: The rSb 22.6 kDa antigen demonstrated cross-reactivity with antibodies in urine from individuals in S. haematobium-endemic communities. The high seropositivity compared to microscopy prevalence may reflect detection of low-intensity infections, past exposure with persistent antibodies, or ongoing transmission intensity in these communities. While the current performance of the assay does not support its use for individual diagnosis, it shows potential for sero-epidemiological surveillance in endemic areas. Further validation studies incorporating molecular diagnostics and longitudinal follow-up will clarify the significance of antibody positivity in the absence of detectable eggs.
CLINICAL TRIAL NUMBER: Not applicable.
METHODS: Urine samples from 559 individuals (290 adults and 269 children; 235 males and 313 females) from four communities and schools in Yewa North Local Government Area, Ogun State, Nigeria, were collected. Samples were examined for S. haematobium eggs by microscopy, screened for anti-schistosomal antibodies using rSb 22.6 kDa ELISA, and analyzed for haematuria, leukocyturia, and proteinuria using reagent strips.
RESULTS: Prevalence by microscopy was 13.9% (78/558), while 54.1% (299/553) of samples were seropositive by ELISA. Among ELISA-positive individuals, 29.8% had haematuria, 47.9% had leukocyturia, and 37.1% had proteinuria. Of 480 microscopy-negative individuals, 221 (46.0%) were ELISA-positive. When microscopy was used as the reference standard, the rSb 22.6 kDa-ELISA showed 46.2% sensitivity and 45.8% specificity. However, ELISA positivity correlated significantly with clinical markers of urogenital pathology (P < 0.05).
CONCLUSION: The rSb 22.6 kDa antigen demonstrated cross-reactivity with antibodies in urine from individuals in S. haematobium-endemic communities. The high seropositivity compared to microscopy prevalence may reflect detection of low-intensity infections, past exposure with persistent antibodies, or ongoing transmission intensity in these communities. While the current performance of the assay does not support its use for individual diagnosis, it shows potential for sero-epidemiological surveillance in endemic areas. Further validation studies incorporating molecular diagnostics and longitudinal follow-up will clarify the significance of antibody positivity in the absence of detectable eggs.
CLINICAL TRIAL NUMBER: Not applicable.